Nothing Special   »   [go: up one dir, main page]

Huang et al., 2015 - Google Patents

Patient-specific dosimetry using pretherapy [124 I] m-iodobenzylguanidine ([124 I] mIBG) dynamic PET/CT imaging before [131 I] mIBG targeted radionuclide therapy …

Huang et al., 2015

View HTML
Document ID
9597668424836081905
Author
Huang S
Bolch W
Lee C
Van Brocklin H
Pampaloni M
Hawkins R
Sznewajs A
DuBois S
Matthay K
Seo Y
Publication year
Publication venue
Molecular imaging and biology

External Links

Snippet

Abstract Purpose Iodine-131-m-iodobenzylguanidine ([131 I] mIBG)-targeted radionuclide therapy (TRT) is a standard treatment for recurrent or refractory neuroblastoma with response rates of 30–40%. The aim of this study is to demonstrate patient-specific dosimetry …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/103—Treatment planning systems
    • A61N5/1031—Treatment planning systems using a specific method of dose optimization
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/0493—Steroids, e.g. cholesterol, testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/02—Devices for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computerised tomographs
    • A61B6/032—Transmission computed tomography [CT]
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/02—Devices for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computerised tomographs
    • A61B6/037—Emission tomography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/50—Clinical applications
    • A61B6/507—Clinical applications involving determination of haemodynamic parameters, e.g. perfusion CT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/50—Clinical applications
    • A61B6/508—Clinical applications for non-human patients
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T11/00—2D [Two Dimensional] image generation
    • G06T11/003—Reconstruction from projections, e.g. tomography
    • G06T11/005—Specific pre-processing for tomographic reconstruction, e.g. calibration, source positioning, rebinning, scatter correction, retrospective gating

Similar Documents

Publication Publication Date Title
Huang et al. Patient-specific dosimetry using pretherapy [124 I] m-iodobenzylguanidine ([124 I] mIBG) dynamic PET/CT imaging before [131 I] mIBG targeted radionuclide therapy for neuroblastoma
Besemer et al. Development and validation of RAPID: a patient-specific Monte Carlo three-dimensional internal dosimetry platform
Kost et al. VIDA: a voxel-based dosimetry method for targeted radionuclide therapy using Geant4
Zaidi Quantitative analysis in nuclear medicine imaging
Paulino et al. FDG-PET in radiotherapy treatment planning: Pandora's box?
Andersson et al. Effective dose to adult patients from 338 radiopharmaceuticals estimated using ICRP biokinetic data, ICRP/ICRU computational reference phantoms and ICRP 2007 tissue weighting factors
Grimes et al. Comparison of internal dose estimates obtained using organ‐level, voxel S value, and Monte Carlo techniques
Graves et al. Dose point kernels for 2,174 radionuclides
Brolin et al. Pharmacokinetic digital phantoms for accuracy assessment of image-based dosimetry in 177Lu-DOTATATE peptide receptor radionuclide therapy
Mauxion et al. Improved realism of hybrid mouse models may not be sufficient to generate reference dosimetric data
Gosewisch et al. 3D Monte Carlo bone marrow dosimetry for Lu-177-PSMA therapy with guidance of non-invasive 3D localization of active bone marrow via Tc-99m-anti-granulocyte antibody SPECT/CT
Howard et al. Comparison of I-131 radioimmunotherapy tumor dosimetry: unit density sphere model versus patient-specific Monte Carlo calculations
He et al. Evaluation of quantitative imaging methods for organ activity and residence time estimation using a population of phantoms having realistic variations in anatomy and uptake
Papadimitroulas et al. A personalized, Monte Carlo‐based method for internal dosimetric evaluation of radiopharmaceuticals in children
Pérez et al. DOSIS: An integrated computational tool for patient-specific dosimetry in nuclear medicine by Monte Carlo and dose point kernel approaches
Kim et al. Comparison of voxel S‐value methods for personalized voxel‐based dosimetry of 177Lu‐DOTATATE
Kayal et al. Generation of clinical 177Lu SPECT/CT images based on Monte Carlo simulation with GATE
Li et al. Heterogeneity of dose distribution in normal tissues in case of radiopharmaceutical therapy with alpha-emitting radionuclides
Mansouri et al. Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu] Lu-DOTATATE radiopharmaceutical therapy
KR102283934B1 (en) Method and system for generating virtual CT(Computed Tomography) image and attenuation-corrected PET(Positron Emission Tomography) image based on PET image
Villoing et al. NCINM: organ dose calculator for patients undergoing nuclear medicine procedures
Kairemo et al. 4D SPECT/CT acquisition for 3D dose calculation and dose planning in 177Lu-peptide receptor radionuclide therapy: applications for clinical routine
Costa et al. Optimization of GATE simulations for whole-body planar scintigraphic acquisitions using the XCAT male phantom with 177Lu-DOTATATE biokinetics in a Siemens Symbia T2
Zvereva et al. Feasibility of reducing differences in estimated doses in nuclear medicine between a patient-specific and a reference phantom
Dieudonné et al. Absorbed-dose calculation for treatment of liver neoplasms with 90 Y-microspheres